The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Oligonucleotide Synthesis-Global Market Insights and Sales Trends 2024

Oligonucleotide Synthesis-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1850710

No of Pages : 103

Ask Your Query

Synopsis

Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.

The global Oligonucleotide Synthesis market size is expected to reach US$ 2946.1 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Oligonucleotide Synthesis in various end use industries. The expanding demands from the Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and Others, are propelling Oligonucleotide Synthesis market. Custom Oligonucleotides, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pre-designed Oligonucleotides segment is estimated at % CAGR for the next seven-year period.

Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by End User. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oligonucleotide Synthesis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Oligonucleotide Synthesis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Oligonucleotide Synthesis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oligonucleotide Synthesis sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Oligonucleotide Synthesis covered in this report include Integrated DNA Technologies, Merck, Eurofins Genomics, Thermo Fisher Scientific, Agilent Technologies, Eurogentec, GE Healthcare, LGC Biosearch Technologies and Nitto Denko Avecia, etc.

The global Oligonucleotide Synthesis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Integrated DNA Technologies
  • Merck
  • Eurofins Genomics
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Eurogentec
  • GE Healthcare
  • LGC Biosearch Technologies
  • Nitto Denko Avecia
  • Genscript
  • Genedesign
  • TriLink Biotechnologies
  • Bio-Synthesis
  • ATDBio

Global Oligonucleotide Synthesis market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Oligonucleotide Synthesis market, Segment by Type:

  • Custom Oligonucleotides
  • Pre-designed Oligonucleotides

Global Oligonucleotide Synthesis market, by End User

  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oligonucleotide Synthesis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Oligonucleotide Synthesis
1.1 Oligonucleotide Synthesis Market Overview
1.1.1 Oligonucleotide Synthesis Product Scope
1.1.2 Oligonucleotide Synthesis Market Status and Outlook
1.2 Global Oligonucleotide Synthesis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Oligonucleotide Synthesis Market Size by Region (2018-2029)
1.4 Global Oligonucleotide Synthesis Historic Market Size by Region (2018-2023)
1.5 Global Oligonucleotide Synthesis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Oligonucleotide Synthesis Market Size (2018-2029)
1.6.1 North America Oligonucleotide Synthesis Market Size (2018-2029)
1.6.2 Europe Oligonucleotide Synthesis Market Size (2018-2029)
1.6.3 Asia-Pacific Oligonucleotide Synthesis Market Size (2018-2029)
1.6.4 Latin America Oligonucleotide Synthesis Market Size (2018-2029)
1.6.5 Middle East & Africa Oligonucleotide Synthesis Market Size (2018-2029)
2 Oligonucleotide Synthesis Market by Type
2.1 Introduction
2.1.1 Custom Oligonucleotides
2.1.2 Pre-designed Oligonucleotides
2.2 Global Oligonucleotide Synthesis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Oligonucleotide Synthesis Historic Market Size by Type (2018-2023)
2.2.2 Global Oligonucleotide Synthesis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Oligonucleotide Synthesis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Oligonucleotide Synthesis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Oligonucleotide Synthesis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Oligonucleotide Synthesis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Oligonucleotide Synthesis Revenue Breakdown by Type (2018-2029)
3 Oligonucleotide Synthesis Market Overview by End User
3.1 Introduction
3.1.1 Academic Research Institutes
3.1.2 Pharmaceutical and Biotechnology Companies
3.1.3 Diagnostic Laboratories
3.1.4 Others
3.2 Global Oligonucleotide Synthesis Market Size by End User: 2018 VS 2022 VS 2029
3.2.1 Global Oligonucleotide Synthesis Historic Market Size by End User (2018-2023)
3.2.2 Global Oligonucleotide Synthesis Forecasted Market Size by End User (2024-2029)
3.3 Key Regions Market Size by End User
3.3.1 North America Oligonucleotide Synthesis Revenue Breakdown by End User (2018-2029)
3.3.2 Europe Oligonucleotide Synthesis Revenue Breakdown by End User (2018-2029)
3.3.3 Asia-Pacific Oligonucleotide Synthesis Revenue Breakdown by End User (2018-2029)
3.3.4 Latin America Oligonucleotide Synthesis Revenue Breakdown by End User (2018-2029)
3.3.5 Middle East and Africa Oligonucleotide Synthesis Revenue Breakdown by End User (2018-2029)
4 Oligonucleotide Synthesis Competition Analysis by Players
4.1 Global Oligonucleotide Synthesis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oligonucleotide Synthesis as of 2022)
4.3 Date of Key Players Enter into Oligonucleotide Synthesis Market
4.4 Global Top Players Oligonucleotide Synthesis Headquarters and Area Served
4.5 Key Players Oligonucleotide Synthesis Product Solution and Service
4.6 Competitive Status
4.6.1 Oligonucleotide Synthesis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Integrated DNA Technologies
5.1.1 Integrated DNA Technologies Profile
5.1.2 Integrated DNA Technologies Main Business
5.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Products, Services and Solutions
5.1.4 Integrated DNA Technologies Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.1.5 Integrated DNA Technologies Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Oligonucleotide Synthesis Products, Services and Solutions
5.2.4 Merck Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Eurofins Genomics
5.3.1 Eurofins Genomics Profile
5.3.2 Eurofins Genomics Main Business
5.3.3 Eurofins Genomics Oligonucleotide Synthesis Products, Services and Solutions
5.3.4 Eurofins Genomics Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Agilent Technologies
5.5.1 Agilent Technologies Profile
5.5.2 Agilent Technologies Main Business
5.5.3 Agilent Technologies Oligonucleotide Synthesis Products, Services and Solutions
5.5.4 Agilent Technologies Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.5.5 Agilent Technologies Recent Developments
5.6 Eurogentec
5.6.1 Eurogentec Profile
5.6.2 Eurogentec Main Business
5.6.3 Eurogentec Oligonucleotide Synthesis Products, Services and Solutions
5.6.4 Eurogentec Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.6.5 Eurogentec Recent Developments
5.7 GE Healthcare
5.7.1 GE Healthcare Profile
5.7.2 GE Healthcare Main Business
5.7.3 GE Healthcare Oligonucleotide Synthesis Products, Services and Solutions
5.7.4 GE Healthcare Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.7.5 GE Healthcare Recent Developments
5.8 LGC Biosearch Technologies
5.8.1 LGC Biosearch Technologies Profile
5.8.2 LGC Biosearch Technologies Main Business
5.8.3 LGC Biosearch Technologies Oligonucleotide Synthesis Products, Services and Solutions
5.8.4 LGC Biosearch Technologies Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.8.5 LGC Biosearch Technologies Recent Developments
5.9 Nitto Denko Avecia
5.9.1 Nitto Denko Avecia Profile
5.9.2 Nitto Denko Avecia Main Business
5.9.3 Nitto Denko Avecia Oligonucleotide Synthesis Products, Services and Solutions
5.9.4 Nitto Denko Avecia Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.9.5 Nitto Denko Avecia Recent Developments
5.10 Genscript
5.10.1 Genscript Profile
5.10.2 Genscript Main Business
5.10.3 Genscript Oligonucleotide Synthesis Products, Services and Solutions
5.10.4 Genscript Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.10.5 Genscript Recent Developments
5.11 Genedesign
5.11.1 Genedesign Profile
5.11.2 Genedesign Main Business
5.11.3 Genedesign Oligonucleotide Synthesis Products, Services and Solutions
5.11.4 Genedesign Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.11.5 Genedesign Recent Developments
5.12 TriLink Biotechnologies
5.12.1 TriLink Biotechnologies Profile
5.12.2 TriLink Biotechnologies Main Business
5.12.3 TriLink Biotechnologies Oligonucleotide Synthesis Products, Services and Solutions
5.12.4 TriLink Biotechnologies Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.12.5 TriLink Biotechnologies Recent Developments
5.13 Bio-Synthesis
5.13.1 Bio-Synthesis Profile
5.13.2 Bio-Synthesis Main Business
5.13.3 Bio-Synthesis Oligonucleotide Synthesis Products, Services and Solutions
5.13.4 Bio-Synthesis Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.13.5 Bio-Synthesis Recent Developments
5.14 ATDBio
5.14.1 ATDBio Profile
5.14.2 ATDBio Main Business
5.14.3 ATDBio Oligonucleotide Synthesis Products, Services and Solutions
5.14.4 ATDBio Oligonucleotide Synthesis Revenue (US$ Million) & (2018-2023)
5.14.5 ATDBio Recent Developments
6 North America
6.1 North America Oligonucleotide Synthesis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Oligonucleotide Synthesis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Oligonucleotide Synthesis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Oligonucleotide Synthesis Market Dynamics
11.1 Oligonucleotide Synthesis Industry Trends
11.2 Oligonucleotide Synthesis Market Drivers
11.3 Oligonucleotide Synthesis Market Challenges
11.4 Oligonucleotide Synthesis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock